Fully Automated Forensic Routine Dried Blood Spot Screening for Workplace Testing.

In this study, we describe the transfer of a new and fully automated workflow for the cost-effective drug screening of large populations based on the dried blood spot (DBS) technology. The method was installed at a routine poison control center and applied for DBS and dried urine spot (DUS) samples. A fast method focusing on the high-interest drugs and an extended screening method were developed on the automated platform. The dried cards were integrated into the automated workflow, in which the cards were checked in a camera recognition system, spiked with deuterated standards via an in-built spraying module and directly extracted. The extract was transferred online to an analytical LC column and then to the electrospray ionization tandem mass spectrometry system. The target compounds were analyzed in positive multiple-reaction monitoring mode. Before each sample batch or analysis day, calibration samples were measured to balance inter-day variations and to avoid false negative samples. An internal standard was integrated prior the sample extraction to allow in process control. A total of 28 target compounds were analyzed and directly extracted within 5 min per sample. This fast screening method was then extended to 20 min, enabling the usage of a Forensic Toxicology Database to screen over 1,200 drugs. The method gives confident positive/negative results for all tested drugs at their individual cut-off concentration. Good precision (±15%, respectively ±20% at limit of quantification) and correlation within the calibration range from 5 to 1,000 ng/mL was obtained. The method was finally applied to real cases from the lab and cross-checked with the existing methodologies.

[1]  L. Mercolini,et al.  Biosampling strategies for emerging drugs of abuse: towards the future of toxicological and forensic analysis. , 2016, Journal of pharmaceutical and biomedical analysis.

[2]  M. Huestis,et al.  Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration. , 2011, Clinical chemistry.

[3]  E. García-Ruiz,et al.  Dried matrix spots and clinical elemental analysis. Current status, difficulties, and opportunities , 2018 .

[4]  B. Chowdhry,et al.  Investigation of different approaches to incorporating internal standard in DBS quantitative bioanalytical workflows and their effect on nullifying hematocrit-based assay bias. , 2015, Analytical chemistry.

[5]  Mário J Dias,et al.  Dried blood spots combined to an UPLC–MS/MS method for the simultaneous determination of drugs of abuse in forensic toxicology , 2018, Journal of pharmaceutical and biomedical analysis.

[6]  J. Henion,et al.  Automated high-capacity on-line extraction and bioanalysis of dried blood spot samples using liquid chromatography/high-resolution accurate mass spectrometry. , 2014, Rapid communications in mass spectrometry : RCM.

[7]  J. Cocho,et al.  Simultaneous determination of cocaine and opiates in dried blood spots by electrospray ionization tandem mass spectrometry. , 2013, Talanta.

[8]  R. Guthrie,et al.  A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS. , 1963, Pediatrics.

[9]  W. Weinmann,et al.  Rapid and simple LC-MS/MS screening of 64 novel psychoactive substances using dried blood spots. , 2014, Drug testing and analysis.

[10]  L. Anzillotti,et al.  Simplifying sample pretreatment: application of dried blood spot (DBS) method to blood samples, including postmortem, for UHPLC-MS/MS analysis of drugs of abuse. , 2014, Forensic science international.

[11]  J. Gaulier,et al.  On-line liquid chromatography/tandem mass spectrometry simultaneous determination of opiates, cocainics and amphetamines in dried blood spots. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  I. Grabnar,et al.  Dried blood spots for monitoring and individualization of antiepileptic drug treatment. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[13]  V. Cebolla,et al.  Fully automated drug screening of dried blood spots using online LC-MS/MS analysis , 2018 .

[14]  L. Morini,et al.  Simple and sensitive screening and quantitative determination of 88 psychoactive drugs and their metabolites in blood through LC-MS/MS: application on postmortem samples. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[15]  M. Moeller,et al.  Determination of drugs of abuse in blood. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[16]  Götz Schlotterbeck,et al.  Extended and Fully Automated Newborn Screening Method for Mass Spectrometry Detection , 2017, International journal of neonatal screening.

[17]  Kathrin Foerster,et al.  Clinical feasibility of dried blood spots: Analytics, validation, and applications. , 2016, Journal of pharmaceutical and biomedical analysis.

[18]  N. Kostić,et al.  Quantitation of pregabalin in dried blood spots and dried plasma spots by validated LC-MS/MS methods. , 2015, Journal of pharmaceutical and biomedical analysis.

[19]  A. Servais,et al.  Beyond dried blood spot: Current microsampling techniques in the context of biomedical applications , 2017 .

[20]  Wonkyung Yang,et al.  An LC-MS/MS method for the simultaneous determination of 15 antipsychotics and two metabolites in hair and its application to rat hair. , 2017, Forensic science international.

[21]  A. Chakrapani,et al.  Newborn screening for inborn errors of metabolism , 2015 .

[22]  M. Battegay,et al.  Automated high throughput analysis of antiretroviral drugs in dried blood spots. , 2017, Journal of mass spectrometry : JMS.